+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 194 Pages
  • Global
From
From
From
Low-Density Lipoprotein Market - Global Forecast 2025-2030 - Product Thumbnail Image

Low-Density Lipoprotein Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
From
From
From
From
From
From
Biobetters - Global Strategic Business Report - Product Thumbnail Image

Biobetters - Global Strategic Business Report

  • Report
  • February 2026
  • 488 Pages
  • Global
From
Ophthalmic Drugs Market Report 2025-2035 - Product Thumbnail Image

Ophthalmic Drugs Market Report 2025-2035

  • Report
  • December 2024
  • 340 Pages
  • Global
From
Loading Indicator